Stock comparison
Revvity
RVTY
Market cap
$10.97B
Sector
Healthcare
Overall winner
Thermo Fisher Scientific
RVTY 2–5 TMO
Thermo Fisher Scientific
TMO
Market cap
$175.7B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
RVTYvsTMO
46D
52C
50D
74B
42D
40D
15F
28F
47D
51D
48D
52D
48D
45D
Side-by-side metrics
| Metric | RVTY | TMO |
|---|---|---|
| Market cap | $10.97B | $175.7B |
| P/E (TTM) | 45.9x | 26.4x |
| EV/EBIT | 38.0x | 27.2x |
| ROIC (TTM) | 2.89% | 7.33% |
| Gross margin | 51.44% | 39.41% |
| Net margin | 8.3% | 15.18% |
| Revenue CAGR 5y | -7.06% | 3.25% |
| EPS CAGR 5y | -28.86% | -2.43% |
| Debt / Equity | 0.5x | 0.8x |
| Dividend yield | 0.28% | 0.36% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
RVTY leads on
- Debt / Equity0.5xvs 0.8x+44%
- Gross margin51.44%vs 39.41%+23%
TMO leads on
- Revenue CAGR 5y3.25%vs -7.06%+146%
- Market cap$175.7Bvs $10.97B+94%
- EPS CAGR 5y-2.43%vs -28.86%+92%
- ROIC (TTM)7.33%vs 2.89%+61%
More like RVTY
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.